Hi-Tech Pharmacal Co. (HITK) Misses Q1 EPS by 24c; Sales Light

September 5, 2012 7:03 AM EDT
Hi-Tech Pharmacal Co. (NASDAQ: HITK) reported Q1 EPS of $0.44, $0.24 worse than the analyst estimate of $0.68. Revenue for the quarter came in at $52 million versus the consensus estimate of $57.6 million.

NOTE: Shares were halted.

For earnings history and earnings-related data on Hi-Tech Pharmacal Co. (HITK) click here.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings, Hot Earnings, Trading Halts

Related Entities

Earnings